Lv43
730 积分 2022-10-26 加入
LC/MS Methods for Studying Lysosomal ADC Catabolism
13天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
26天前
已完结
Development and validation of pharmacokinetics assays for a novel HER2-targeting antibody-drug conjugate (SHR-A1201): Application to its dose-escalation pharmacokinetic study
2个月前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
3个月前
已完结
An update on the importance of plasma protein binding in drug discovery and development
3个月前
已完结
Discovery of MD-265: A Potent MDM2 Degrader That Achieves Complete Tumor Regression and Improves Long-Term Survival of Mice with Leukemia
4个月前
已完结
Development and Validation of a Cell-Based Binding Neutralizing Antibody Assay for an Antibody–Drug Conjugate
5个月前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
5个月前
已完结
Concentration-dependent plasma protein binding: Expect the unexpected
6个月前
已完结
Degrader–Antibody Conjugates: Emerging New Modality
6个月前
已完结
皖公网安备34019202002308
